✦ LIBER ✦

Calorie-counting compared to exchange system diets in the treatment of overweight patients with type II diabetes

✍ Scribed by Wing, Rena R.; Nowalk, Mary Patricia; Epstein, Leonard H.; Koeske, Randi

Book ID: 123003967
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 543 KB
Volume: 11
Category: Article
ISSN: 0306-4603
DOI: 10.1016/0306-4603(86)90041-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Patient freedom to choose a weight loss

Patient freedom to choose a weight loss diet in the treatment of overweight and obesity: a randomized dietary intervention in type 2 diabetes and pre-diabetes

✍ Coles, Leah T; Fletcher, Elly A; Galbraith, Claire E; Clifton, Peter M 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 877 KB

Pravastatin compared to bezafibrate in t

Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated patients with Type 2 diabetes mellitus

✍ C. Rustemeijer; J. A. Schouten; H. J. Voerman; H. E. S. J. Hensgens; A. J. M. Do 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Background Both HMG-CoA reductase inhibitors and ®bric acid derivates are used for the treatment of dyslipidemia in Type 2 diabetes patients. The aim of this study was to compare the lipid lowering effect of 40 mg pravastatin, a HMG-CoA reductase inhibitor, and 400 mg beza®brate, a ®bric acid deriva

Validation of a tool to assess medicatio

Validation of a tool to assess medication treatment satisfaction in patients with Type 2 diabetes: the Diabetes Medication System Rating Questionnaire (DMSRQ)

✍ M. Peyrot; Q. Harshaw; A. C. Shillington; Y. Xu; R. R. Rubin 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

PDB8 FEWER TREATMENT CHANGES WITH PREMIX

PDB8 FEWER TREATMENT CHANGES WITH PREMIXED INSULIN ANALOGUES COMPARED TO PREMIXED HUMAN INSULIN–A REAL-LIFE TREATMENT PATTERN ANALYSIS OF PATIENTS WITH TYPE 2 DIABETES IN THE NETHERLANDS

✍ TL Thomsen; E Heintjes; FJA Penning; T Christensen; RMC Herings 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

Six Months of Treatment with the Endosco

Six Months of Treatment with the Endoscopic Duodenal-Jejunal Bypass Liner Does Not Lead to Decreased Systemic Inflammation in Obese Patients with Type 2 Diabetes

✍ Jonge, Charlotte; Rensen, Sander S.; D’Agnolo, Hedwig M. A.; Bouvy, Nicole D.; B 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 165 KB